Fagan Associates, Inc. Buys Advanced Micro Devices Inc, Sarepta Therapeutics Inc, Boston Scientific Corp, Sells Regeneron Pharmaceuticals Inc, Take-Two Interactive Software Inc, The Mosaic Co

• New Purchases: AMD, SRPT, CONE, OHI, ITOT, AXP, ED,
• Added Positions: DIS, BSX, EQIX, CVX, T, FB, AAPL, UNH, LOW, BND, GVA, STNE, BNDX, C, BABA, MSFT, GOOGL, BRK.B, VNQI, DAL, BAC, LULU, WMT, AGG, SCHM, CGC, SCHV, TGT, NKE, IBM, CSCO, HPT, JNJ, MPW, AMRN, SCHG, UTX, BA, XOM, XLK, GE, SCHE, PFE, AMZN, XLE, CRM, IWM, CMCSA, FNB, GPN, VZ, PRAH,
• Reduced Positions: INTC, SDY, SCHA, CVS, FLRN, EFA, UAL, TOT, GD, EMR, SCHX, XLV,
• Sold Out: REGN, TTWO, MOS, NEWR, BMY, FLR,

For the details of FAGAN ASSOCIATES, INC.'s stock buys and sells, go to https://www.gurufocus.com/guru/fagan+associates%2C+inc./current-portfolio/portfolioportfolio

1. Apple Inc (AAPL) - 74,427 shares, 5.99% of the total portfolio. Shares added by 2.02%
2. Microsoft Corp (MSFT) - 97,770 shares, 5.33% of the total portfolio. Shares added by 1.22%
3. Alphabet Inc (GOOGL) - 10,779 shares, 4.75% of the total portfolio. Shares added by 1.35%
4. Mastercard Inc (MA) - 34,527 shares, 3.72% of the total portfolio. Shares added by 0.06%
5. Facebook Inc (FB) - 46,313 shares, 3.64% of the total portfolio. Shares added by 3.51%

Fagan Associates, Inc. initiated holding in Advanced Micro Devices Inc. The purchase prices were between $26.24 and $33.23, with an estimated average price of $28.48. The stock is now traded at around $33.21. The impact to a portfolio due to this purchase was 0.78%. The holding were 63,470 shares as of .

Fagan Associates, Inc. initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $112.21 and $151.95, with an estimated average price of $121.45. The stock is now traded at around $156.10. The impact to a portfolio due to this purchase was 0.38%. The holding were 6,170 shares as of .

Fagan Associates, Inc. initiated holding in CyrusOne Inc. The purchase prices were between $52.73 and $63.72, with an estimated average price of $58.64. The stock is now traded at around $58.89. The impact to a portfolio due to this purchase was 0.11%. The holding were 4,505 shares as of .

Fagan Associates, Inc. initiated holding in Omega Healthcare Investors Inc. The purchase prices were between $34.95 and $38.16, with an estimated average price of $36.45. The stock is now traded at around $36.96. The impact to a portfolio due to this purchase was 0.1%. The holding were 6,640 shares as of .

Fagan Associates, Inc. initiated holding in iShares Core S&P Total U.S. Stock Market. The purchase prices were between $62.13 and $66.91, with an estimated average price of $65.23. The stock is now traded at around $68.22. The impact to a portfolio due to this purchase was 0.09%. The holding were 3,155 shares as of .

Fagan Associates, Inc. initiated holding in American Express Co. The purchase prices were between $109.85 and $124.92, with an estimated average price of $117.43. The stock is now traded at around $127.96. The impact to a portfolio due to this purchase was 0.08%. The holding were 1,660 shares as of .

Fagan Associates, Inc. added to a holding in Boston Scientific Corp by 34.56%. The purchase prices were between $34.91 and $42.98, with an estimated average price of $38.41. The stock is now traded at around $42.25. The impact to a portfolio due to this purchase was 0.16%. The holding were 36,680 shares as of .

Fagan Associates, Inc. added to a holding in Chevron Corp by 33.83%. The purchase prices were between $113.85 and $126.68, with an estimated average price of $120.87. The stock is now traded at around $125.98. The impact to a portfolio due to this purchase was 0.13%. The holding were 10,029 shares as of .

Fagan Associates, Inc. added to a holding in AT&T Inc by 21.00%. The purchase prices were between $30.3 and $33.51, with an estimated average price of $31.77. The stock is now traded at around $33.65. The impact to a portfolio due to this purchase was 0.12%. The holding were 51,268 shares as of .

Fagan Associates, Inc. added to a holding in StoneCo Ltd by 36.18%. The purchase prices were between $24.69 and $42.93, with an estimated average price of $29.32. The stock is now traded at around $33.82. The impact to a portfolio due to this purchase was 0.07%. The holding were 22,245 shares as of .

Fagan Associates, Inc. added to a holding in Granite Construction Inc by 73.78%. The purchase prices were between $40.03 and $48.18, with an estimated average price of $43.71. The stock is now traded at around $43.38. The impact to a portfolio due to this purchase was 0.07%. The holding were 8,385 shares as of .

Fagan Associates, Inc. added to a holding in iShares Core U.S. Aggregate Bond by 20.80%. The purchase prices were between $107.29 and $111.16, with an estimated average price of $108.84. The stock is now traded at around $110.79. The impact to a portfolio due to this purchase was 0.05%. The holding were 6,261 shares as of .

Fagan Associates, Inc. sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $299.6 and $414.82, with an estimated average price of $332.61.

Fagan Associates, Inc. sold out a holding in Take-Two Interactive Software Inc. The sale prices were between $89.74 and $113.83, with an estimated average price of $102.76.

Fagan Associates, Inc. sold out a holding in The Mosaic Co. The sale prices were between $21.27 and $27.92, with an estimated average price of $24.41.

Fagan Associates, Inc. sold out a holding in New Relic Inc. The sale prices were between $86.51 and $108.45, with an estimated average price of $98.73.

Fagan Associates, Inc. sold out a holding in Fluor Corp. The sale prices were between $27.72 and $41.56, with an estimated average price of $33.55.

Fagan Associates, Inc. sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $44.62 and $49.34, with an estimated average price of $46.57.